GHRP-6 is normally always manufactured as lyophilized (freeze-dried) powder contained in vials in amounts of 5mg. Some companies might manufacture amounts greater or lesser than 5mg per vial, but the standard is generally 5mg/vial. The lyophilized powder contained within the vial will need to be reconstituted with bacteriostatic water in order for it to be injected. After reconstitution, the solution must then be refrigerated in storage. If left in hot environments or in room temperature environments for extended periods of time, the protein structure will degrade and become ineffective. For reconstitution, users will typically mix 3ml of bacteriostatic water with the powder gently. However, users can and do frequently reconstitute the powder with less (or more) water which will yield different concentrations of GHRP-6. For example, reconstitution of 5mg of powder with 3ml of water will yield GHRP-6 doses of 166mcg per 0.1ml (or 10iu on an insulin syringe).
Mod GRF 1-29 and CJC-1295 are still being researched. As such, they are not yet medically utilized or approved. Though some firm protocols for the use of these peptides have been developed, the dosage of the compound is not yet medically confirmed. In a study conducted by researchers on 21 to 61 year-old subjects, it was found that depending on the dose, the concentrations of the growth hormone increased to up to 10 times for at least 6 days. Also, the concentration of IGF-1 increased to up to 3 times for 9 to 11 days.
As a result, a general guideline for the purpose of achieving performance and physique enhancement is that of 100mcg administered three times per day. Each injection should be spaced evenly apart in order to achieve substantial HGH levels throughout the day due to the short half-life of GHRP-6 as well as the pulsatile manner of the HGH release that it causes. For greater results that would include more pronounced muscle gain and fat loss, more frequent injections would be required above the three times per day protocol. More details concerning the specific administration timing will be described shortly.
"From the 1st click, my experience with Elite Sarms was great. My order was confirmed within seconds, packed & shipped that day, & delivered so quickly! Hyper Lean was my first sarms experience, & noticed an effect within a couple days. My diet has remained constant - food groups, cals, macro ratios - all the same - & have really leaned out in a short time! My body resisted change for months of dieting, carb cycling, & various training forms - up & down, & my constant stress levels didn't help at all. But with Hyper Lean I've found it does exactly what it says it does - metabolism is up as I drop fat & increase mass. I've had no negative side effects. And the strength - I find that the metabolism boost aids my recovery & my energy output, despite being in a slight caloric deficit I'm gaining muscle, and my previous PRs are history - after 6 months of struggles I feel like an athlete again! Thanks Elite Sarms - I'm impressed! " EP
Like all other steroidal drugs, GHRP-6 too has a few side effects which will be discussed below. It is because of these side effects, the drug is not available over the counter without a prescription. The most common side effect users report is aggravated hunger. All GHRP's are known to escalate hunger in users and GHRP-6 is no exception. Studies show that GHRP-6 has the highest potential when it comes to increasing hunger among users. This agonizing hunger is said to subside, after the consumption of an appropriate meal. Users have reported the gradual diminishing of this side effect but it remains throughout the entire cycle of administration.
In June 2010, the National Drugs and Poisons Schedule Committee (NDPSC) considered the scheduling of paracetamol in combination with ibuprofen. Paracetamol preparations containing 500 mg or less of paracetamol as the only therapeutically active constituent (other than phenylephrine, effervescent agents or guaiphenesin) in packs of 25 or less were exempt from scheduling. However, when these preparations were combined with another therapeutically active ingredient they became Schedule 2. The NDPSC considered that the Schedule 2 entry remained appropriate, but noted the possibility that more robust evidence of additional risk could come to light through any application for product approval with the Therapeutic Goods Administration. The delegate confirmed the NDPSC's decision and the reasons for the decision in August 2010.

CJC-1295 is basically a peptide hormone that acts similar to growth hormone releasing hormones (GHRH). Invented by a Canadian biotechnology company called ConjuChem, it is beneficial to athletes because it can bioconjugate with circulating albumin and increase the time it can be used for medical purposes. It achieves this by preventing degradation of its amino acids. With a single dose, it can remain in the body for quite a few days and can cause the growth hormone to be released many times per day. This reduces the frequency of injections needed.

Mostly, these peptides are sold as lyophilized powder in 2mg containers. Bacteriostatic water should be mixed with the powder in order to reconstitute it. To make the dosage of 100mcg per injection, 2ml bacteriostatic water should be mixed into 2mg of lyophilized powder. This reconstituted mixture should be then injected inside the muscles or under the skin. The mixture should be kept under refrigeration at all times otherwise it will degenerate and will not be effective anymore.


In 1999, seven adult patients with GH deficiency and LV failure received hexarelin administrations. The GH response to hexarelin was negligible in these patients. Moreover, hexarelin administration increased their left ventricular ejection fraction (LVEF) without changing catecholamine levels, mean blood pressure (MBP), or cardiac output. For the first time, the acute administration of hexarelin proved to induce a positive inotropic effect in humans, which is GH independent and mediated by specific myocardial receptors for a GH secretagogue peptide.29 A subsequent study involving hexarelin administration to normal adults, severe GH-deficient patients (N = 7), and patients with severe ischemic DCM (N = 12) confirmed that the acute administration of hexarelin exerts a GH-independent positive inotropic effect likely mediated by specific GHRP myocardial receptors.30 This pioneering group subsequently evaluated the cardiac performances of the acute hexarelin administration (2.0 µg/kg, i.v.) in patients undergoing bypass surgery in comparison to patients given GH-releasing hormone, recombinant human GH, or placebo. The study concluded that the acute administration of hexarelin improved cardiac performance without any relevant variation in systemic vascular resistance and induced a reduction of wedge pressure and, significantly, that these cardiotropic effects were not shown by the other concurrent interventions.31
You will learn that no single method of using Ipamorelin is right or wrong, and there is more than one route (and dosage cycle length) you can choose, when you do incorporate Ipamorelin into your diet and exercise regimen. Regardless of how high or how long the dosage cycle is, you want to start off on the lower end when you are new to using Ipamorelin, or any growth hormone for that matter. Not only will this reduce the potential risk of experience the side effects, it also ensures your body will ingest the highest levels into the bloodstream. And, it will allow you to gradually increase the dosage and cycle lengths, in order to eventually get to the ideal levels which work best for your body, and for the intended/desired goals you are trying to achieve when using Ipamorelin daily.
As previously explained, multiple GHRP-6 doses are required throughout the day due to the pulsatile nature of the HGH release, and the administration of these doses are typically administered on average 3 times daily spaced evenly apart. More administrations are acceptable for greater effects on physique and performance, but it is advised that approximately 3 hours in between each injection is ensured so as to allow the pituitary gland to restore its storage of HGH. The most common protocol is as follows:

GH secretagogues differ from exogenous rHGH in their effects primarily because endogenous GH contains all five isoforms of growth hormone, whereas exogenous GH contains only the 20 kilodalton isoform. Different isoforms affect tissues in discreet ways that the 20 kDa isoform cannot. Administration of GH secretagogues causes a pulse-release of GH from the pituitary which is cleared from the body within a few hours. This does not significantly raise plasma insulin-like growth factor 1 (IGF-1) levels.[citation needed]
×